Goldline Pharmaceutical IPO
Goldline Pharmaceutical IPO Pages
Listed
on 18 May 2026
· BSE SME
Issue Price
₹43
Listing Price
₹59
Day 1 Gain
+38.95%
Subscription
769.61x
Goldline Pharmaceutical Share Price
Updated 17 Jun 2026, 08:16 UTCCurrent Price
₹43.99
Issue Price
₹43
Return vs Issue
+2.30%
Market price is delayed up to ~15 minutes, shown for information only — not investment advice.
Key Dates
Open Date
12 May 2026
Close Date
14 May 2026
Listed On
18 May 2026
IPO Details
- Type
- Sme
- Exchange
- BSE SME
- Country
- India
- Sector
- Healthcare & Pharma
- Regulator
- SEBI
Frequently Asked Questions
What is the price band of Goldline Pharmaceutical IPO?
The price band of Goldline Pharmaceutical IPO is ₹43–₹43 per share.
What is the lot size and minimum investment for Goldline Pharmaceutical IPO?
The lot size is 3000 shares. Retail investors need a minimum investment of ₹129,000 to apply.
When does Goldline Pharmaceutical IPO open and close?
Goldline Pharmaceutical IPO opens on 12 May 2026 and closes on 14 May 2026.
When will Goldline Pharmaceutical IPO be listed?
Goldline Pharmaceutical IPO is expected to list on 18 May 2026 on BSE SME.
What is the current GMP of Goldline Pharmaceutical IPO?
The latest GMP for Goldline Pharmaceutical IPO is ₹15 (premium). This suggests an estimated listing price of ₹58.